Kato et al. [37] have reported that treatment of oral cancer cells with EGCG partially reversed the hypermethylation status of the RECK gene and significantly enhanced the expression level of RECK mRNA, leading to reduced MMP-2 and MMP-9 expressions. The gene discussed is RECK; the disease is lip and oral cavity carcinoma.